Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jing Wu Capsule (精乌胶囊) is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Guizhou Shengshilongfang Pharmaceutical. It is administered orally in capsule form and is indicated to tonify the liver and kidney, benefit essence and blood, and strengthen tendons and bones. The medication is primarily used to treat symptoms associated with liver and kidney deficiency, such as insomnia with excessive dreaming, tinnitus, forgetfulness, hair loss, and premature graying of the hair and beard. As a complex herbal mixture, it does not have a single defined biological target in Western pharmacology, but rather exerts its effects through the synergistic properties of its constituent botanical ingredients. It is currently approved and marketed in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jing Wu Capsule.